Summary of InMode Conference Call Company Overview - **Company**: InMode - **Industry**: Medical Devices, specifically in aesthetic treatments Key Points Current Operational Challenges - InMode is currently operating at approximately **60% manufacturing capacity** due to regional instability and threats from neighboring countries [5][6] - The company faces significant **logistical challenges** with shipping, as major carriers like DHL and FedEx are not operating flights to Israel, leading to increased shipping costs [6][7] - Employee attendance is affected by school closures, impacting workforce availability [6] Inventory Management - InMode has built a **safety inventory** of finished goods and components over the past two years, which is currently being utilized to meet market demands despite shipping challenges [11] - The company has shipped products to subsidiaries globally to fill gaps caused by local disruptions [11] Share Buyback Program - InMode has executed a **share buyback program**, purchasing shares worth **$508 million** to date, with an additional **$85 million to $90 million** approved for buyback, totaling around **$600 million** over the last 3.5 years [14][15] - The company aims to maintain liquidity for potential M&A opportunities, targeting acquisitions in the range of **$500 million to $1 billion** [17] Market Trends and Customer Insights - There is a **stabilization** in patient activity and treatment usage, with no significant growth or decline observed [19] - High interest rates on leasing (14%-15%) are affecting customer purchasing decisions, particularly in the U.S. market [20] - The company anticipates potential growth in 2027, contingent on stabilization in 2026 and new product launches [22][33] Product and Technology Development - InMode is focusing on expanding its portfolio to include **non-invasive technologies**, which now contribute nearly **20%** to its revenue [34] - The company is developing new laser technologies to complement its existing RF energy products, aiming for a competitive edge in the market [36][39] - A dedicated team for the **dry eye treatment** platform has been established, with plans to submit for FDA approval for a new RF-based study [41][42] Geographic and Structural Changes - InMode has restructured its North American operations to unify management, aiming for improved efficiency and sales performance [29][30] - The company is also exploring growth opportunities in Asia, particularly in China and Korea, where it currently has limited market presence [46][47] Financial Outlook - Gross margins are impacted by a shift towards more laser-based devices, which traditionally have lower margins, and by tariffs affecting U.S. operations [49][50] - Despite current challenges, there is optimism about the recovery of demand for aesthetic procedures, which is expected to improve margins in the future [51] Additional Insights - The company is cautious about future guidance due to macroeconomic uncertainties and ongoing regional instability [22][50] - InMode's management is actively monitoring the effectiveness of recent organizational changes and is prepared to make further adjustments as necessary [30][32]

Investment Rating - The report initiates coverage with a "Buy" rating for the company [6][7]. Core Insights - The company is a global leader in optical crystals, leveraging technology from the Chinese Academy of Sciences to maintain a strong market position in nonlinear optical crystals and laser materials [6][17]. - The company has diversified its product offerings into three main categories: crystal components, precision optical components, and laser devices, enhancing its market robustness [6][26]. - The growth in the ultrafast laser and solid-state laser markets is expected to drive significant revenue increases, with projected revenues of 11.6 billion, 14.9 billion, and 19.4 billion yuan from 2025 to 2027 [7][8]. Financial Data and Profit Forecast - Total revenue is forecasted to be 1,156 million yuan in 2025, with a year-on-year growth rate of 32.1% [5]. - The net profit attributable to the parent company is expected to reach 262 million yuan in 2025, reflecting a growth rate of 19.7% [5]. - The company maintains a gross margin of approximately 54% across its product lines, indicating strong profitability [5][41]. Market Position and Competitive Landscape - The company holds a leading market share in the nonlinear optical crystal segment, with a 70% share in the global market for BBO crystals [70]. - The optical crystal market is projected to grow significantly, driven by applications in laser technology, medical devices, and optical communication [60][46]. - The company is positioned to benefit from the domestic substitution trend in optical components, particularly in the context of increasing demand for optical isolators and Faraday rotators [6][9]. Product and Technology Development - The company has established a comprehensive production capability from magnetic optical crystals to Faraday rotators, enhancing its competitive edge in the optical communication sector [6][9]. - The establishment of its subsidiary, Zhiqi Photon, has accelerated growth in precision optical components, achieving a revenue of 49.05 million yuan in the first half of 2025, a 73.66% increase year-on-year [28][29]. - The company’s focus on R&D and innovation has led to multiple awards and recognitions, reinforcing its reputation in the optical materials industry [24][25].

Core Viewpoint - The passing of Professor Zhou Bingkun, a pioneer in laser and optoelectronics in China, represents a significant loss for Tsinghua University and the broader field of laser and optoelectronics in the country [5]. Group 1: Contributions to Science and Education - Zhou Bingkun was instrumental in establishing the laser research group at Tsinghua University in 1962, leading to the creation of the laser (optoelectronics) discipline and the development of solid-state lasers and their applications [3]. - He was the first to develop high-efficiency, long-lifetime, narrow-linewidth, and frequency-stable semiconductor laser-pumped solid-state lasers, opening new avenues in solid-state laser technology [3]. - Zhou's research in optoelectronics led to significant advancements, including crystal fiber growth, fiber amplifiers, wavelength division multiplexing, and time division multiplexing in optical communication, earning him multiple national awards [3]. Group 2: Educational Impact - Zhou Bingkun authored the textbook "Principles of Laser" in 1980, which became a classic in the field and has been revised to the seventh edition, nurturing generations of talent in optics and optoelectronics [4]. - His students have become leaders in the field, reflecting his commitment to education and mentorship [4]. - Zhou encouraged young scholars to find their research direction, embrace challenges, and seize opportunities, embodying his own life philosophy [4]. Group 3: Legacy and Recognition - Zhou Bingkun held numerous prestigious positions, including President of the Chinese Optical Society and Vice President of the International Optical Society, contributing to the governance of scientific research in China [2]. - He was elected as an academician of the Chinese Academy of Sciences in 1991 and received various honors for his contributions to science and technology [2][3]. - His life and work exemplified the spirit of Tsinghua University, characterized by self-improvement and moral integrity, earning him deep respect and admiration from colleagues and students [4].

Core Viewpoint - The passing of Professor Zhou Bingkun, a pioneer in laser and optoelectronics in China, represents a significant loss for Tsinghua University and the broader field of laser and optoelectronics in the country [5]. Group 1: Contributions to Science and Education - Zhou Bingkun was a foundational figure in the field of laser and optoelectronics, having established the laser research group at Tsinghua University in 1962 and led the development of solid-state lasers and their applications [3]. - He was instrumental in creating high-efficiency, long-lifetime, narrow-linewidth, and frequency-stable semiconductor laser-pumped solid-state lasers, which opened new avenues in solid-state laser technology [3]. - Zhou authored the textbook "Principles of Laser" in 1980, which became a classic in the field and has been revised to its 7th edition, significantly contributing to the education of numerous students in optics and optoelectronics [4]. Group 2: Recognition and Awards - Throughout his career, Zhou received multiple prestigious awards, including the National Science and Technology Progress Award, National Technology Invention Award, and the He Liang He Li Foundation Science and Technology Progress Award, recognizing his significant contributions to science and technology [3]. - He was elected as an academician of the Chinese Academy of Sciences in 1991 and served in various leadership roles within scientific organizations, further highlighting his influence in the scientific community [3]. Group 3: Legacy and Influence - Zhou's dedication to teaching and mentoring has resulted in a large number of outstanding talents in the field, many of whom have become leaders in optoelectronics [4]. - His personal philosophy emphasized the importance of moral integrity, exploration of truth, and a commitment to education, which has left a lasting impact on his students and colleagues [4].

Core Viewpoint - The company has shown significant growth in revenue and net profit for the first nine months of 2025, indicating strong operational performance and market acceptance of its products [2]. Financial Performance - The company achieved a revenue of 1.62 billion yuan for the period from January to September 2025, representing a year-on-year growth of 24.51% [2]. - The net profit attributable to the parent company reached 904 million yuan, with a year-on-year increase of 24.61% [2]. Business Development - The company's laser welding control systems have gained recognition in the industry, and its market share for high-power laser cutting systems continues to rise [3]. - The company is actively expanding into precision processing and overseas markets, indicating a strategic focus on growth and diversification [3]. Institutional Holdings Analysis - As of September 30, 2025, Hong Kong Central Clearing Limited has increased its holdings, while some Sci-Tech Innovation Board ETFs have reduced their positions [4].

Financial Data and Key Metrics Changes - Total revenue for Q4 2025 was $103.9 million, up from $97.9 million in Q4 2024, while full-year revenue for 2025 totaled $370.5 million, a 6% decrease compared to 2024 [8][9] - Gross margins for Q4 2025 were 78% on a GAAP basis, down from 79% in Q4 2024, while non-GAAP gross margins were 79% for both Q4 and full year 2025 [9][11] - GAAP diluted earnings per share for Q4 2025 were $0.42, compared to $1.14 in Q4 2024, and $1.43 for the full year 2025, down from $2.25 in 2024 [11][12] Business Line Data and Key Metrics Changes - Revenue from consumables and services increased slightly compared to last year, indicating early signs of stabilization in patient activity [4] - Minimally invasive technology platforms accounted for 76% of total revenues in Q4 2025, while consumables and services represented 22% of revenue, up from 20% in 2024 [9][10] Market Data and Key Metrics Changes - Sales outside the U.S. totaled $48.5 million in Q4 2025, representing 47% of total sales and a 38% increase compared to Q4 2024, driven primarily by Europe [9] - For the full year 2025, sales outside the U.S. accounted for $171.8 million, or 46% of total sales, representing a 15% increase compared to 2024 [9] Company Strategy and Development Direction - The company views 2026 as a stabilization year following a prolonged period of industry softness, with plans to continue innovating and introducing new platforms [4][6] - A specialized sales team has been established for the Envision platform, aimed at increasing penetration and improving sales productivity [5] - The company plans to launch two new platforms in 2026, including a Korean-made Pico laser device and a device combining new Morpheus technology with Erbium YAG laser [6] Management's Comments on Operating Environment and Future Outlook - Management noted that the industry has not yet fully recovered from the global economic slowdown, with demand in North America remaining below historical levels, but there are early signs of stabilization [7] - The CEO mentioned that interest rates starting to come down could positively impact leasing packages for capital equipment purchases [17] Other Important Information - The company returned $127.4 million to shareholders through a disciplined share repurchase program [13] - The board of directors is exploring strategic alternatives to improve company value, having engaged Bank of America for assistance [20] Q&A Session Summary Question: What signs suggest improving trends in the market? - Management noted a slight increase in procedures and sales in consumables, along with declining interest rates as positive indicators [17] Question: Can you provide updates on strategic alternatives? - The board is considering several strategic alternatives and has engaged Bank of America for assistance, with management not directly involved in the process [20] Question: What are the expectations for gross margins and EBIT margins? - Management indicated that new product launches, particularly lasers, may impact gross margins, and guidance is conservative based on past experiences [27][28] Question: How is the ApexRF platform performing? - The ApexRF platform is being sold alongside other products without a specialized sales team, and management is awaiting FDA indications before pushing it further [72] Question: What is the contribution of new product launches for 2026? - Two new products are expected to be launched in 2026, with significant marketing efforts planned, although specific financial contributions are not yet provided [41]

Financial Data and Key Metrics Changes - Total revenue for Q4 2025 was $103.9 million, up from $97.9 million in Q4 2024, while full-year revenue totaled $370.5 million, a 6% decrease compared to 2024 [8][9] - Gross margins for Q4 2025 were 78% on a GAAP basis, down from 79% in Q4 2024, while non-GAAP gross margins were 79% for both Q4 and full year 2025 [9][11] - GAAP diluted earnings per share for Q4 were $0.42, compared to $1.14 in Q4 2024, and $1.43 for the full year 2025, down from $2.25 in 2024 [11][12] Business Line Data and Key Metrics Changes - Revenue from consumables and services increased slightly compared to last year, indicating early signs of stabilization in patient activity [4] - Minimally invasive technology platforms accounted for 76% of total revenues in Q4 2025, while consumables and services represented 22% of revenue, up from 20% in 2024 [9][10] Market Data and Key Metrics Changes - Sales outside the U.S. totaled $48.5 million in Q4 2025, representing 47% of total sales and a 38% increase compared to Q4 2024, driven primarily by Europe [9] - For the full year 2025, sales outside the U.S. accounted for $171.8 million, or 46% of total sales, a 15% increase compared to 2024 [9] Company Strategy and Development Direction - The company views 2026 as a stabilization year following a prolonged period of industry softness, with expectations for revenue to be broadly in line with 2025 [4][7] - Product innovation is a key pillar of the strategy, with plans to launch two new platforms in 2026, including a Korean-made Pico laser device and a device combining new Morpheus technology with Erbium YAG laser [6][7] - The sales force is now segmented across aesthetic and wellness, with a dedicated team for specific platforms to drive increased penetration and improve sales productivity [5] Management's Comments on Operating Environment and Future Outlook - Management noted that the industry has not yet fully recovered from the global economic slowdown, with demand in North America remaining below historical levels, but there are early signs of stabilization in the U.S. and gradual improvement in Europe [7] - The CEO mentioned that interest rates starting to come down could positively impact leasing packages for capital equipment purchases, which may encourage more sales [16] Other Important Information - The company returned $127.4 million to shareholders through a disciplined share repurchase program [12] - The board of directors is exploring strategic alternatives to improve company value, having engaged Bank of America for assistance [19] Q&A Session Summary Question: What signs suggest improving trends in the market? - Management noted a slight increase in procedures and sales in consumables, along with declining interest rates as positive indicators [16] Question: Can you provide updates on strategic alternatives? - The board is considering several strategic alternatives to enhance company value, with management not directly involved in the process [19] Question: What are the expectations for gross margins and EBIT margins? - Management indicated that new product launches, particularly lasers, may impact gross margins, and guidance is conservative based on past experiences [27][28] Question: How significant is the laser market for future growth? - The CEO emphasized that laser platforms are essential for growth, despite being in a saturated market with lower margins compared to existing products [31][32] Question: What is the status of the dry eye indication and FDA approval timelines? - The company is working on FDA approval for a bipolar RF device for dry eye treatment, with studies expected to last through 2026 and possibly into 2027 [64][65]

Investment Rating - The industry investment rating is "Overweight" indicating that the industry is expected to outperform the overall market [9]. Core Insights - The rising silver prices have intensified cost pressures in the photovoltaic (PV) industry, making "de-silvering" a pressing need for mass production of batteries. N-type batteries (TOPCon, HJT, BC, etc.) have become the mainstream technology route, significantly increasing silver consumption per watt compared to traditional P-type batteries. The price surge of silver, a core raw material for PV cell paste, has directly impacted manufacturing costs and profit margins in the industry [4][3]. - Laser technology is playing a crucial role in the de-silvering transition of the PV industry, enhancing its standard attributes. Laser transfer technology can save 30%-40% of silver paste while improving battery conversion efficiency by over 0.3%. This technology is compatible with various high-efficiency battery routes [4][3]. - Key company highlighted is Dier Laser, recognized as a champion in PV laser equipment, covering the entire technology route of photovoltaics. The company has successfully delivered laser transfer equipment for mass production and has received orders for high-precision laser graphic equipment for copper plating processes [4][3]. Summary by Sections Industry Overview - The report emphasizes the urgent need for the PV industry to reduce reliance on high-priced silver due to rising costs, with silver paste's share in component costs increasing from 12.8% to 21.4% [4]. Technology Insights - Laser transfer technology is identified as a core support for the de-silvering transition, offering advantages such as reduced silver paste consumption and improved efficiency. Other technologies mentioned include high-precision laser graphic equipment and laser sintering processes [4][3]. Key Company Analysis - Dier Laser is noted for its comprehensive coverage of PV technology routes, with successful applications of laser transfer and graphic equipment in mass production. The company is positioned to benefit from the industry's shift towards de-silvering technologies [4][3].

Core Viewpoint - Inno Laser (301021.SZ) expects a net profit attributable to shareholders of 38 million to 50 million yuan for 2025, representing a year-on-year growth of 74.06% to 129.02%. The net profit after deducting non-recurring gains and losses is projected to be 24 million to 36 million yuan, indicating a growth of 152.19% to 278.29% compared to the previous year [1]. Group 1 - The company focuses on addressing industry pain points and deepening innovative solutions, leading to significant improvements in core capabilities and operational performance [1]. - The core laser business continues to lead the market with record-high shipment volumes [1]. - The laser module business has made breakthroughs in new areas such as PCB, showing substantial growth [1]. Group 2 - The medical device CDMO business has achieved milestone progress, preparing for mass production for clients in the heart valve industry [1]. - The company has successfully completed the first phase of R&D for high-power thin-slice laser projects and launched prototypes for continuous deep ultraviolet lasers and 500W ultrafast lasers [1]. - Future plans include leveraging deep technical expertise in solid-state lasers to tackle core technologies for shorter pulse and wavelength lasers, aiming to maintain and enhance industry leadership in solid-state nanosecond and ultrafast laser technologies and applications [1].

Core Viewpoint - The article highlights the significant advancements in optical technology in China, emphasizing the contributions of scientists like Jiang Huilin and the importance of laser technology in various fields, including defense, medicine, and agriculture [1][2][3]. Group 1: Contributions of Jiang Huilin - Jiang Huilin, an 80-year-old academician, works tirelessly, dedicating 10 hours a day to research, driven by a sense of urgency to contribute to national needs [4][10]. - He has inherited the "patriotism in optics" from his mentor, Wang Daheng, and aims to continue the legacy of advancing China's optical technology [5][6]. - Jiang's research has led to significant developments, including the "special vehicle dynamic performance testing system" and advancements in laser communication technology, which are crucial for national security [8][9]. Group 2: Importance of Laser Technology - Laser communication technology is highlighted as a revolutionary advancement, capable of transmitting data at speeds ten times faster than traditional methods, with strong security and anti-interference capabilities [9]. - In modern medicine, laser technology is utilized for precise diagnostics and treatments, such as laser surgery for tumors and endoscopic procedures [9]. - The application of laser technology extends to agriculture, where it is used for smart weeding and crop breeding, showcasing its versatility and potential impact on various sectors [9]. Group 3: Vision for the Future - Jiang expresses a commitment to achieving China's goal of becoming a technological powerhouse by 2035, emphasizing the need for continuous improvement and innovation in optical technology [10][11]. - The article concludes with a call for future generations to carry on the legacy of scientific pursuit, highlighting the collective effort of scientists in transforming China's optical capabilities from a state of backwardness to a position of leadership [11].